Beatriz Korc-Grodzicki

Dr. Beatriz Korc-Grodzicki heads the geriatrics service at MSKCC and has investigated checkpoint inhibitor therapy outcomes and toxicity in older cancer patients. She has examined how age and frailty affect immune-related adverse event profiles and clinical benefit from immunotherapy. Her work informs geriatric assessment-guided immunotherapy selection and monitoring protocols for older patients who represent an increasing proportion of those receiving checkpoint inhibitors.